Defective Product Attorneys of Friedman, Rodman & Frank, P.A., Fight for Patients Suffering From Complications Due to Transvaginal Mesh Implants
In July, the Food and Drug Administration (FDA) issued an update related to what it called 'serious complications' related to the use of vaginal mesh for treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI).

August 18, 2011 /24-7PressRelease/ -- In July, the Food and Drug Administration (FDA) issued an update related to what it called 'serious complications' related to the use of vaginal mesh for treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI).

It is now known that complications linked to transvaginal placement of surgical mesh in SUI and POP patients are not rare and can require multiple surgeries to correct problems related to the use of surgical mesh. In fact, the FDA now says that additional surgeries may actually not be able to repair damage caused by implantation of the mesh.

Known complications of the transvaginal placement of surgical mesh include:

- Erosion of the implanted mesh
- Infection and/or bleeding
- Pain, including pain during sexual intercourse
- Problems with organs near the implantation site

The defective products attorneys of Friedman, Rodman & Frank, P.A., will represent patients who've experienced complications from the transvaginal placement of surgical mesh throughout the United States. From their offices in South Florida, the personal injury law firm is ready to help women who have suffered unnecessarily because of a medical product, transvaginal surgical mesh, which was supposed to help, not hurt, them.

Press Release Contact Information:

Findlaw PR
Website: Visit Our Website